Loading insider details...
Beta
Latest Form 4 (Jun 16, 2026): Grant/Award of 40,565 CRDF shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 40,565 | n/a |
| Jun 27, 2025 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 40,565 | n/a |
| Jul 1, 2024 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 29,700 | n/a |
| Jun 20, 2023 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 27,700 | n/a |
| Sep 20, 2022 | Cardiff Oncology, Inc. (CRDF) | Purchase | 15,000 | $24.5K |
| Jul 6, 2022 | Cardiff Oncology, Inc. (CRDF) | Exercise/Conversion | 28,858 | $75.0K |
| Mar 10, 2022 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 26,800 | n/a |
| Jun 14, 2021 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 22,000 | n/a |
| Jun 19, 2020 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 28,858 | n/a |
| May 18, 2020 | Cardiff Oncology, Inc. (CRDF) | Purchase | 69,930 | $100.0K |